COI.
close Submit Innovation
close
Pharma verified Verified Outcome TRL 9

Global Supply Chain ERP Modernization

domain Client: A global pharmaceutical distributor handshake Provider: SAP S/4HANA schedule Deploy: 2023
85 Impact
Enterprise Ready
Evidence Score: A/10
Strength: High

Executive Summary

ANALYST: COI RESEARCH

Consolidation of fragmented legacy ERPs into a single digital core to manage global distribution of pharmaceuticals and medical products.

rate_review Analyst Verdict

"High Risk / High Reward. Large-scale ERP migrations are notorious for delay, but essential for global serialization compliance (DSCSA) and inventory visibility."

lock
Full Audit Report Available Includes Risk Register, Technical Specs & Compliance Data.

warning The Challenge

Following M&A activity, the organization operated on disparate legacy ERP systems, creating data silos that hindered real-time visibility into inventory and complicated compliance with global track-and-trace regulations.

psychology The Solution

Migrated to SAP S/4HANA as the unified digital core. This modernization supported the rebranding to Cencora and enabled a single global view of finance and supply chain operations.

settings_suggest Technical & Deployment Specs

Integrations
WMS / TMS
Deployment Model
Private Cloud
Data Classification
Financial / Logistics
Estimated TCO / ROI
Very High
POC Summary ( to )

"N/A"

shield Risk Register & Mitigation

Risk Factor Severity Mitigation Strategy
Implementation Failure High Phased rollout

trending_up Impact Trajectory

Audited value realization curve

Unified processes across global footprint Verified Outcome
Primary KPIEnhanced DSCSA (Track & Trace) compliance capabilities
Audit CycleImproved inventory turnover visibility

policy Compliance & Gov

  • Standards: SOX / DSCSA
  • Maturity (TRL): 9
  • Evidence Score: A/10
  • Data Class: Financial / Logistics

folder_shared Verified Assets

description
Verified Case Study
PDF • Version 1
lock
verified_user
Technical Audit
PDF • Audited
lock
Security Architecture

The "Blind Verification" Protocol

How we verified these outcomes for A global pharmaceutical distributor without exposing sensitive IP or identities.

Private
lock_person

1. Raw Evidence

Audit ID: #PRIV-492
Evidence: Direct SQL Logs
Public
public

2. Verified Asset

Outcome: Verified
Ref ID: #COI-492

Strategic Action Center

Identify your current stage and take the next step.

rocket_launch
Replicate This Success
Want similar results? Request a deployment consultation.
psychology_alt
Submit Challenge
Have a different problem? Submit your problem statement.
publish
Publish Case Study
Submit your own verified evidence.
thumb_up
Verify Impact
Audit your existing solution.